NL-OMON26731尚未招募不适用
A multi-center randomized, open label, controlled study in primary liver transplantation comparing long term renal function in recipients treated with standard dose extended release tacrolimus alone and recipients treated with a combination of low dose extended release tacrolimus and low dose sirolimus.
Foundation for Liver and Gastrointestinal Research (SLO)Department of Gastroenterology & HepatologyErasmus Medical Center Rotterdam‘s Gravendijkwal 230, Room HA 2043015 CE Rotterdam, The NetherlandsTel: +31 10 703 5942 Fax: +31 10 436 59160 个研究点目标入组 196 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 196
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Primary liver transplantation or retransplantation within 14 days after first transplantation;
- •2. Use of Advagraf at least 2 weeks prior to randomization;
排除标准
- •1. Treatment with investigational drugs within 3 months before start of therapy;
- •2. Multi organ transplantation;
研究者
相似试验
进行中（未招募）
1 期
This study is to examine whether the combination of a low dose of a new drug Sirolimus in combination with a low dose of the standard anti-rejection medication Tacrolimus is safer and works equally well in patients after liver transplantation.iver transplantationMedDRA version: 19.0Level: LLTClassification code 10050434Term: Prophylaxis against liver transplant rejectionSystem Organ Class: 100000004865EUCTR2009-017843-32-NLFoundation of Liver Research (SLO)
已完成
3 期
A multi-center randomized, open label, controlled study in primary liver transplantation comparing long term renal function in recipients treated with standard dose extended release tacrolimus alone and recipients treated with a combination of low dose extended-release tacrolimus and low dose sirolimus.Liver transplantationreplacing a bad functioning liver by an organ from a donor1001965410029149NL-OMON44991Stichting Leveronderzoek196
进行中（未招募）
1 期
A multi-center, randomized, open label, controlled study to compare the Sustained Virological Response during treatment with Neoral or tacrolimus in maintenance liver transplant recipients treated with pegylated interferon and ribavirin for recurrent Hepatitis C - NDChronic Hepatitis C in post-liver transplantationMedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2009-010806-12-ITOVARTIS FARMA
进行中（未招募）
不适用
A multi-center, randomized, open label, controlled study to compare the Sustained Virological Response during treatment with Neoral or tacrolimus in maintenance livertransplant recipients treated with pegylated interferon and ribavirin for recurrent Hepatitis C - SUSTAIRecurrence of Hepatitis C in post-liver transplantationMedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CMedDRA version: 9.1Level: LLTClassification code 10024716Term: Liver transplantationEUCTR2009-010806-12-FRovartis Pharma Services AG355
进行中（未招募）
不适用
A multi-center, randomized, open label, controlled study to compare the Sustained Virological Response during treatment with Neoral or tacrolimus in maintenance livertransplant recipients treated with pegylated interferon and ribavirin for recurrent Hepatitis C - SUSTAIChronic Hepatitis C in post-liver transplantationMedDRA version: 14.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10024716Term: Liver transplantationSystem Organ Class: 100000004865EUCTR2009-010806-12-DEovartis Pharma Services AG92